Article
No association between genetic polymorphisms in NAD(P)H oxidase p22phox and paraoxonase 1 and colorectal cancer risk.
Anticancer research - 1 Jan 2000
Van Der Logt Elise M J, Janssen Cynthia H J M, Van Hooijdonk Zairah, Roelofs Hennie M J, Wobbes Theo, Nagengast Fokko M, Peters Wilbert H M
Abstract excerpt
BACKGROUND: Impaired metabolism of ingested toxic or carcinogenic compounds is a postulated mechanism underlying colorectal cancer (CRC). Furthermore, it is suggested that reactive oxygen species (ROS) may play a role in human cancer development. Polymorphic variations in NAD(P)H oxidase p22phox and paraoxonase 1 (PON1) enzyme activities may alter superoxide production or the rate of chemical metabolism,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
